Food News and Research

RSS

New drug shows promise for phenylketonuria

PKU is described by scientists as an autosomal recessive genetic disease that is characterized by a deficiency in an enzyme called phenylalanine hydroxylase (PAH).

15 Jan 2009

Barriers to effective FDA regulation of nanotechnology-based dietary supplements

The ability of the Food and Drug Administration (FDA) to regulate the safety of dietary supplements using nanomaterials is severely limited by lack of information, lack of resources and the agency's lack of statutory authority in certain critical areas, according to a new expert report released by the Project on Emerging Nanotechnologies (PEN).

15 Jan 2009

Midlife caffeine intake lowers risk of late-life dementia

Midlife coffee drinking can decrease the risk of dementia/Alzheimer's disease (AD) later in life.

15 Jan 2009

Researchers study asymmetry in the brain

A tug-of-war between the two sides of the brain causes it to become asymmetrical, according to research published today in the journal Neuron.

15 Jan 2009

Strong relationship between our health as adults and our early diet

If you have trouble keeping weight off and you're wondering why - the surprising answer may well be the cheeseburgers you ate - when you were a toddler.

15 Jan 2009

Calories in recipes have gradually increased over time

Recent research presented at the U.S. Department of Agriculture (USDA) Small Changes Summit that addresses childhood obesity shows that calories in recipes have gradually increased over time.

15 Jan 2009

Pasture-based farming passes the taste test and is healthier too

Cattle and sheep grazed on natural grasslands help maintain biodiversity and produce tastier, healthier meat, according to a study funded by the Economic and Social Research Council (ESRC).

15 Jan 2009

Important relationship between fetal and adolescent alcohol experiences

Rats whose mothers were fed alcohol during pregnancy are more attracted to the smell of liquor during puberty.

15 Jan 2009

FDA launches pilot program to improve drug safety and active drug ingredients produced outside U.S.

The U.S. Food and Drug Administration today announced the launch of a voluntary pilot program that would help promote the safety of drugs and active drug ingredients produced outside the United States.

14 Jan 2009

New folate antagonists selectively target pathway important in rheumatoid arthritis

Methotrexate (MTX), a folate antagonist that blocks folic acid activity, is the most widely used disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis.

13 Jan 2009

High caffeine consumption linked to hallucinations

High caffeine consumption could be linked to a greater tendency to hallucinate, a new research study suggests.

13 Jan 2009

Potential health consequences of recession

The Bureau of Labor Statistics just announced a jump in the jobless rate, from 6.8 percent in November to 7.2 percent in December.

13 Jan 2009

Scientists unlock secret to overeating

CANCER RESEARCH UK scientists have found new evidence that the tendency to overeat could be genetic according to research published in the International Journal of Obesity.

13 Jan 2009

Food-addiction blamed for obesity

A study by scientists in New Zealand say craving something sweet like a biscuit or piece of chocolate could be a response to an addiction.

13 Jan 2009

Pfizer joins URMC initiative for safety of experimental drugs

Pfizer Inc. has agreed to provide the University of Rochester Medical Center (URMC) with a unique set of electrocardiographic data that will help researchers develop new methods to ensure the safety of experimental drugs.

12 Jan 2009

New mouse model for peanut allergy

Chicago researchers report the development of a new mouse model for food allergy that mimics symptoms generated during a human allergic reaction to peanuts.

12 Jan 2009

GSK and XenoPort resubmit NDA for Solzira in restless legs syndrome

GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

12 Jan 2009